PANS (Pediatric Acute-onset Neuropsychiatric Syndrome) and PANDAS (Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections) are conditions characterized by the sudden, dramatic onset of neuropsychiatric symptoms in children.
PANS (Pediatric Acute-onset Neuropsychiatric Syndrome) is a clinical diagnosis given to children who experience a dramatic — sometimes overnight — onset of neuropsychiatric symptoms, including obsessive-compulsive behaviors and/or food restriction. Diagnostic criteria for PANS were developed in 2012 by the National Institute of Mental Health (NIMH).
PANDAS (Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections) is a subset of PANS. In PANDAS, the sudden onset of symptoms is specifically associated with a documented Group A Streptococcal infection, such as strep throat or scarlet fever.
Both conditions are thought to involve an abnormal immune response that affects the brain. In PANDAS, the immune system's response to strep bacteria is believed to mistakenly affect areas of the brain involved in movement and behavior, similar to the mechanism seen in Rheumatic Fever. The cause of PANS more broadly may involve infections, metabolic disturbances, and other inflammatory processes.
It is important to note that PANS and PANDAS remain areas of active research. Diagnosis can be challenging, and not all clinicians have equal familiarity with these conditions.
PANS/PANDAS is the same thing as OCD or an anxiety disorder.
While PANS/PANDAS involves OCD-like symptoms, the defining feature is the sudden, dramatic onset — not a gradual development over time. The underlying mechanism (an abnormal immune response) distinguishes it from typical OCD or anxiety disorders, though these distinctions are still being refined through ongoing research.
If a child is acting out, it's a behavioral problem.
Extreme behavioral changes in PANS/PANDAS — including rage, anxiety, or apparent defiance — are recognized as neurological symptoms, not simply misbehavior. Research from the NIMH and Stanford Medicine Children's Health describes these presentations as part of the condition's symptom profile.
PANS/PANDAS is very well understood and easy to diagnose.
Diagnosis remains challenging. There are currently no confirmed biomarkers, and clinical criteria require careful application. Research is ongoing, and clinical management guidance continues to evolve. This is noted explicitly in medical literature from the NIH and peer-reviewed research.
Diagnosis of PANS/PANDAS is clinical — meaning it is based on the child's symptom presentation, history, and response to infection-related triggers, rather than a single definitive test. A physician evaluates the child's symptom onset, severity, and course, and rules out other conditions.
For PANDAS specifically, testing for a recent streptococcal infection (such as a throat culture or blood tests for strep antibodies) is part of the diagnostic process.
Treatment approaches may include:
A multidisciplinary team — which may include a pediatrician, neurologist, psychiatrist, and immunologist — is often involved. Families are encouraged to work with clinicians who are familiar with PANS/PANDAS specifically.
The following organizations provide additional information. Heart & Hope Project is not affiliated with these organizations.
NIMH — Information about PANS/PANDAS https://www.nimh.nih.gov/research/research-conducted-at-nimh/research-areas/clinics-and-labs/sbp/information-about-pans-pandas Stanford Medicine Children's Health — What are PANS and PANDAS? https://www.stanfordchildrens.org/en/services/pans-pandas/what-are-pans-pandas.html NCBI StatPearls — PANDAS Overview https://www.ncbi.nlm.nih.gov/books/NBK606088/ PANDAS Network (Patient Advocacy) https://www.pandasnetwork.org/